Feature | July 30, 2014

TOPS Breast Center Study Shows Addition of 3-D Imaging Increases Breast Cancer Detection Rate

July 30, 2014 — The addition of tomosynthesis, a 3-D breast imaging technique, to digital mammography in more than 170,000 examinations was associated with a decrease in the proportion of patients called back for additional imaging and an increase in the cancer detection rate, according to a study in the June 25, 2014, issue of JAMA. TOPS Comprehensive Breast Center in Houston was part of the study conducted by medical director Stephen L. Rose, M.D., and colleagues.

Screening mammography has played a key role in reducing breast cancer mortality, although it has drawn criticism for excessive false-positive results, limited sensitivity and the potential of over-diagnosis of clinically insignificant lesions. In 2011, tomosynthesis was approved by the U.S. Food and Drug Administration (FDA) to be used in combination with standard digital mammography for breast cancer screening. Single-institution studies have shown that adding tomosynthesis to mammography increases cancer detection and reduces false-positive results, according to background information in the article.

The study utilized data from 13 centers to determine if mammography combined with tomosynthesis improves performance of breast screening programs. A total of 454,850 examinations were evaluated. Researchers compared screening digital mammography alone (281,187 cases) against the performance after tomosynthesis was added to mammography (173,663 cases) at 13 sites in geographically diverse regions across the United States.

The primary measured outcomes were recall rate, cancer detection rate, positive predictive value for recall and positive predictive value for biopsy. An analysis of the data indicated the model-adjusted rates per 1,000 screens were as follows: for recall rate, 107 with digital mammography vs. 91 with digital mammography + tomosynthesis (an overall decrease in recall rate of 16 per 1,000 screens); for biopsies, 18.1 with digital mammography vs. 19.3 with digital mammography + tomosynthesis; for cancer detection, 4.2 with digital mammography vs. 5.4 with digital mammography + tomosynthesis; and for invasive cancer detection, 2.9 with digital mammography vs. 4.1 with digital mammography + tomosynthesis.

Adding tomosynthesis increased the positive predictive value for recall from 4.3 percent to 6.4 percent and for biopsy from 24.2 percent to 29.2 percent.

“This study should put to rest much of the current confusion over the benefits of mammography. With this new technology, tomosynthesis (3-D mammography), we can significantly reduce the patient anxiety generated by recalls for additional imaging. Simultaneously, the new technology will increase the accuracy of traditional digital mammography in the early detection of invasive tumors,” said Rose.

Rose and Andra Tidwell, BSRT, imaging director of TOPS Comprehensive Breast Center, also published a study last year in the American Journal of Radiology comparing 3-D screening with the prior year’s standard digital mammography. The study actually demonstrated a 37 percent reduction in recalls and more than a 50 percent increase in the early detection of invasive tumors. “I truly believe that as experience grows with 3-D mammography, we will see the recall rates continue to drop, and we will detect tumors earlier when less treatment is required. This is a very exciting study for all women undergoing screening mammography,” said Rose.

For more information: www.jamanetwork.com

Related Content

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
News | Clinical Trials | February 03, 2020
February 3, 2020 — Melding the genetic and cellular analysis of tumors with how they appear in medical images could g
Automated Triage of Thyroid Cancer

73-year-old man with papillary carcinoma of left lobe of thyroid. Screen shot shows example of thyroid nodule annotation (segmentation and TI-RADS annotation) performed on ultrasound image in longitudinal projection with electronic Physician Annotation Device software (Stanford Medicine Radiology). Radiologists performed nodule segmentation by selecting points (red) on nodule outline (green), while controlling smoothing of outline polygon by means of spline interpolation.

News | Ultrasound Imaging | January 30, 2020
January 30, 2020 — According to an ar...
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...